Integrative Community Therapy (ICT) Intervention Arm for Chronic Disease

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Geisinger Primary Care South Wilkes-Barre, Wilkes-Barre, PA
Chronic Disease
Intervention: Integrative Community Therapy-based Psychodrama - Behavioral
Eligibility
< 18
All Sexes
What conditions do you have?
Select

Study Summary

Investigators are building a program that uses improvisation to teach kids and teens with medical issues healthy ways to cope. Medical issues have been linked to anxiety and depression. Doing theatre can prevent these complications. Participants will meet in groups of about ten for ten weeks to do improvisation that is fun and supportive. Participants will meet with a study team member before the program starts, after the program ends, six months after the program ends, and twelve months after the program ends. At these visits, participants will be screened for anxiety, depression, quality of life, and will be given a short interview.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

4 Primary · 0 Secondary · Reporting Duration: Baseline to 12 months

Baseline to 12 months
Anxiety and Depression
Disease-Related Quality of Life
Empathy
Knowledge and Utilization of Coping Strategies

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Integrative Community Therapy (ICT) Intervention Arm
1 of 2
Improvisational Theatre Arm
1 of 2
Experimental Treatment
Non-Treatment Group

80 Total Participants · 2 Treatment Groups

Primary Treatment: Integrative Community Therapy (ICT) Intervention Arm · Has Placebo Group · N/A

Integrative Community Therapy (ICT) Intervention Arm
Behavioral
Experimental Group · 1 Intervention: Intervention: Integrative Community Therapy-based Psychodrama · Intervention Types: Behavioral
Improvisational Theatre Arm
Behavioral
ShamComparator Group · 1 Intervention: Control: Improvisational Theatre · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline to 12 months
Closest Location: Geisinger Primary Care South Wilkes-Barre · Wilkes-Barre, PA
N/AFirst Recorded Clinical Trial
1 TrialsResearching Chronic Disease
0 CompletedClinical Trials

Eligibility Criteria

Age < 18 · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are between the ages of 5 and 17 years old.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References